Notes Payable - Additional Information (Details)					3 Months Ended	6 Months Ended
	Mar. 09, 2023 $ / shares shares	Feb. 04, 2021 USD ($) shares	May 01, 2020 USD ($) shares	Apr. 16, 2020 USD ($) Days $ / shares	Jun. 30, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jul. 05, 2023 USD ($)	May 01, 2023 USD ($)	Mar. 31, 2023 USD ($)	[1]	Dec. 31, 2022 USD ($)		Jun. 30, 2022 USD ($)	[1]	Mar. 31, 2022 USD ($)	[1]	Dec. 31, 2021 USD ($)	[1]	Jun. 01, 2021 USD ($)
Debt Instrument [Line Items]
Common stock value					$ 1,000	$ 1,000					$ 1,000
Warrants issued | shares			0
Stockholders' equity					26,378,000	26,378,000			$ 33,620,000		$ 42,213,000	[1]	$ 104,902,000		$ 110,380,000		$ 117,422,000
Subsequent Event
Debt Instrument [Line Items]
NYSE 30-day average market capitalization							$ 50,000,000
Stockholders' equity							$ 50,000,000
Cowen Investments and Chardan
Debt Instrument [Line Items]
Aggregate settlement of investment shares | shares			125,885
Debt instrument face amount			$ 2,700,000
Cowen Investments
Debt Instrument [Line Items]
Aggregate settlement of investment shares | shares			107,002
Debt instrument face amount			$ 2,300,000
Business combination contingent consideration liability except accrued interest payable		$ 0
Conversion of Note, shares | shares		86,620	86,620
Chardan
Debt Instrument [Line Items]
Aggregate settlement of investment shares | shares			18,883
Debt instrument face amount			$ 405,000		$ 0	$ 0		$ 405,000
Business combination contingent consideration liability except accrued interest payable								$ 0
Conversion of Note, shares | shares			15,285
Convertible Notes
Debt Instrument [Line Items]
Debt instrument term						5 years
Debt instrument face amount																			$ 200,000,000
Debt issuance costs																			$ 11,400,000
Interest Nominal Rate					6.125%	6.125%
Debt instrument, frequency of fee						semi-annually
Debt instrument, commencement date						Dec. 01, 2021
Conversion of Note, shares | shares	3,386,243
Debt instrument, convertible price per share | $ / shares	$ 59.063
Debt instrument interest rate terms						the second anniversary of the issuance of the Merger Convertible Notes, subject to a holder’s prior right to convert, if the last reported sale price of the Parent Common Stock exceeds 130% of the conversion price for at least 20 trading days during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter.
Derivative liabilities					$ 0	$ 0
Outstanding amount of convertible notes					192,800,000	192,800,000
Contractual interest expense					3,100,000	6,100,000
Amortization of debt issuance costs					551,000	$ 1,100,000
Debt instrument repurchase price percentage upon fundamental change						100.00%
Convertible Notes | Second Anniversary
Debt Instrument [Line Items]
Convertible notes, threshold percentage						130.00%
Convertible Notes | Wilmington Trust National Association
Debt Instrument [Line Items]
Debt issuance costs					$ 200,000,000	$ 200,000,000
Cowen and Company, LLC and Chardan Capital markets, LLC
Debt Instrument [Line Items]
Business combination transaction related costs				$ 5,400,000
mGage | Convertible Notes
Debt Instrument [Line Items]
Voting power					50.00%	50.00%
Resale Registration Statement | Cowen and Company, LLC and Chardan Capital markets, LLC
Debt Instrument [Line Items]
Common stock value				$ 2,700,000
Warrants exercise price | $ / shares				$ 0.01
Beneficial ownership limitation percentage				4.99%
Settlement shares, threshold percentage				15.00%
Settlement shares, trailing days | Days				10
Resale Registration Statement | Cowen and Company, LLC and Chardan Capital markets, LLC | Convertible Notes
Debt Instrument [Line Items]
Convertible notes				$ 2,700,000
Debt instrument term				3 years
Repaid earlier interest rate issuance term				1 year
Repaid after interest rate issuance term				2 years
Convertible notes, threshold percentage				5.00%
Convertible notes, trailing days | Days				10
Interest Nominal Rate				5.00%

[1] Amounts as of December 31, 2022 and before that date differ from those published in the Company's prior consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1 - Description of Organization and Business Operations). Specifically, the number of shares of common stock outstanding during periods before the Reverse Stock Split were divided by the split ratio of 3.5:1, such that each 3.5 shares of common stock were combined and reconstituted into one share of common stock effective March 9, 2023. Fractional shares were not issued in connection with the Reverse Stock Split. Stockholders, who otherwise would have been entitled to receive fractional shares because they held a number of shares not evenly divisible by the split ratio, received an additional fraction of a share of common stock to round up to the next whole share.